glucose, (beta-d)-isomer has been researched along with Metabolic Diseases in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 4 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Echouffo-Tcheugui, JB; Lewsey, SC; Weiss, RG | 1 |
| Bai, XL; Deng, XL; Jin, S; Li, WJ; Wu, GJ | 1 |
| Gollapalli, BP; Gorantala, J; Magani, SKJ; Mupparthi, SD; Shukla, D; Tantravahi, S; Tiwari, AK; Yarla, NS | 1 |
| Du, G; Gao, X; Li, X; Qin, X; Tian, J; Wu, X; Zhou, Y | 1 |
| Chen, R; Fan, G; Wu, XY; Yi, H; Zhao, CC | 1 |
| Avetisyan, LG; Babakhanyan, MA; Chavushyan, VA; Hovhannisyian, LE; Isoyan, AS; Nahapetyan, KH; Simonyan, GM; Simonyan, KV; Simonyan, MA; Simonyan, RM | 1 |
3 review(s) available for glucose, (beta-d)-isomer and Metabolic Diseases
| Article | Year |
|---|---|
Rhodiola and salidroside in the treatment of metabolic disorders.
Topics: AMP-Activated Protein Kinases; Anti-Inflammatory Agents; Antioxidants; Autophagy; Glucosides; Humans; Metabolic Diseases; Mitochondria; Phenols; Plant Extracts; Rhodiola | 2019 |
Salidroside - Can it be a Multifunctional Drug?
Topics: Animals; Antineoplastic Agents; Diabetes Mellitus; Glucosides; Humans; Hypoglycemic Agents; Hypoxia; Metabolic Diseases; Neoplasms; Neurodegenerative Diseases; Neuroprotective Agents; Phenols; Rhodiola; Wounds and Injuries | 2020 |
The Therapeutic Effects and Mechanisms of Salidroside on Cardiovascular and Metabolic Diseases: An Updated Review.
Topics: Animals; Cardiovascular Diseases; Glucosides; Humans; Metabolic Diseases; Phenols | 2021 |
3 other study(ies) available for glucose, (beta-d)-isomer and Metabolic Diseases
| Article | Year |
|---|---|
SGLT2 inhibitors: further evidence for heart failure with preserved ejection fraction as a metabolic disease?
Topics: Aged; Benzhydryl Compounds; Clinical Trials, Phase III as Topic; Female; Glucosides; Heart Failure; Hospitalization; Humans; Male; Metabolic Diseases; Middle Aged; Randomized Controlled Trials as Topic; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Stroke Volume; Treatment Outcome; Ventricular Function, Left | 2021 |
Liquiritin protects PC12 cells from corticosterone-induced neurotoxicity via regulation of metabolic disorders, attenuation ERK1/2-NF-κB pathway, activation Nrf2-Keap1 pathway, and inhibition mitochondrial apoptosis pathway.
Topics: Animals; Apoptosis; Corticosterone; Flavanones; Glucosides; Glycyrrhiza; Kelch-Like ECH-Associated Protein 1; MAP Kinase Signaling System; Metabolic Diseases; Mitochondria; Neuroprotective Agents; NF-E2-Related Factor 2; NF-kappa B; PC12 Cells; Rats | 2020 |
Effects of stevia on synaptic plasticity and NADPH oxidase level of CNS in conditions of metabolic disorders caused by fructose.
Topics: Action Potentials; Animals; Brain; Brain Chemistry; Dietary Sugars; Diterpenes, Kaurane; Fructose; Glucosides; Male; Metabolic Diseases; NADPH Oxidases; Neuronal Plasticity; Rats; Stevia | 2017 |